好色先生

好色先生

Explore the latest content from across our publications

Log In

Forgot Password?
Create New Account

Loading... please wait

2020 Annual Meeting | S22 - Practice, Policy, and Ethics: Improving Patient Care and the Rise of Telemedicine

Monday 04/27/20
03:30 PM - 05:30 PM Add To Calendar
This program will be presented both in-person and online
This program is not expected to be available in the meeting's On Demand product.
Scientific Platform Session
Dina Jacobs, MD, David Q. Beversdorf, MD, FAAN
Practice, Policy, and Ethics
2.00 CME credits
Event Timeline
03:30 PM - 03:42 PM Abstract 001 - Neuro-hospitalist Program Increases Out-patient Productivity and Reduces Turnover
Kelly Baldwin, MD
03:42 PM - 03:54 PM Abstract 002 - Geographical Distribution of Neurologists in the United States
Kyra Curtis, MD
03:54 PM - 04:06 PM Abstract 003 - Analyzing the Online Presence of Neurologists in the United States
Sama Elrahi, MD
04:06 PM - 04:18 PM Abstract 004 - Early Inpatient Readmissions of Acute Care Neurology Patients to Higher Level of Care Units: Opportunity for Quality Improvement in Transitions of Care
Amanda M. Crooks, MD
04:18 PM - 04:30 PM Abstract 005 - Converting to Atraumatic Lumbar Puncture Needles; Experience from the National Hospital for Neurology and Neurosurgery, Queen Square, London, UK
Pawel Obrocki, MBBS
04:30 PM - 04:42 PM Abstract 006 - Teleneurology for Epilepsy: Improving Access to Care in Rural Nebraska
Proleta Datta, MD
04:42 PM - 04:54 PM Abstract 007 - The Use of Leadership Training to Improve Access to Care in a Deployed Setting
Virginia Baker, MD
04:54 PM - 05:06 PM Abstract 008 - Implementation of a Risk-Stratified Multiple Sclerosis Treatment Algorithm: Improved Quality and Affordability
Annette M. Langer-Gould, MD, PhD
05:18 PM - 05:30 PM Abstract 010 - Kaiser Permanente's Rational, Risk-Stratified, Cost-Sensitive Multiple Sclerosis Treatment Algorithm
Annette M. Langer-Gould, MD, PhD
Faculty Disclosures
Neil R. Holland, MBBS, FAAN Dr. Holland has nothing to disclose.
David Q. Beversdorf, MD, FAAN Dr. Beversdorf has received personal compensation in the range of $0-$499 for serving as a Consultant for Yamo pharmaceuticals. Dr. Beversdorf has received personal compensation in the range of $5,000-$9,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Elsevier (Research in Autism Spectrum Disorders). The institution of Dr. Beversdorf has received research support from Autism Research Institute. Dr. Beversdorf has received personal compensation in the range of $5,000-$9,999 for serving as a Case Consultant with Best Doctors.
Annette M. Langer-Gould, MD, PhD An immediate family member of Dr. Langer-Gould has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Annals of American Thoracic Society. The institution of Dr. Langer-Gould has received research support from PCORI. The institution of an immediate family member of Dr. Langer-Gould has received research support from PCORI, ARQ, NIH. Dr. Langer-Gould has a non-compensated relationship as a Voting Member with ICER CTAF Panel that is relevant to AAN interests or activities.
Dina Jacobs, MD Dr. Jacobs has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen . Dr. Jacobs has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Genentech. Dr. Jacobs has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for EMD Serono. Dr. Jacobs has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Banner Life Sciences . Dr. Jacobs has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Bristol Myers Squibb. Dr. Jacobs has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sanofi Genzyme. Dr. Jacobs has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Cycle Pharmaceuticals. Dr. Jacobs has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Horizon. Dr. Jacobs has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Dr. Jacobs has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for EMD Serono. The institution of Dr. Jacobs has received research support from Biogen . The institution of Dr. Jacobs has received research support from Genentech .
Allen S. Nielsen, MD No disclosure on file
Kelly Baldwin, MD Dr. Baldwin has nothing to disclose.
Sonu M. Brara, MD No disclosure on file
Megan Brosious No disclosure on file
Casey Olm-Shipman, MD Dr. Olm-Shipman has nothing to disclose.
Nawaz Hack, MD Dr. Hack has nothing to disclose.
Ross W. Paterson, PhD, MRCP No disclosure on file
Brandon E. Beaber, MD No disclosure on file
Anthony Noto, MD Dr. Noto has nothing to disclose.
Drew Thodeson, MD Dr. Thodeson has nothing to disclose.
Julie DeBacker, MD Dr. DeBacker has nothing to disclose.
Stephen W. Cheng, MD No disclosure on file
Virginia Baker, MD Dr. Baker has nothing to disclose.
Oluwasheyi A. Ayeni, MD No disclosure on file
Proleta Datta, MD The institution of Dr. Datta has received research support from Great Plains IDeA-CTR Pilot grant. Dr. Datta has received personal compensation in the range of $5,000-$9,999 for serving as a Medical Expert with US Dept of Transportation, FMCSA.
Prashant K. Rai, MD Dr. Rai has nothing to disclose.
Jessica B. Smith, MPH Ms. Smith has nothing to disclose.
No disclosure on file
Pawel Obrocki, MBBS No disclosure on file
Amanda M. Crooks, MD No disclosure on file
Sama Elrahi, MD Ms. Elrahi has nothing to disclose.
Jason A. Park No disclosure on file
Kyra Curtis, MD Ms. Curtis has nothing to disclose.
Bonnie Li Bonnie Li has received personal compensation for serving as an employee of Kaiser Permanente.